Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Concise guidance on identifying budgeting flaws early and applying simple corrections to avoid debt and build security.
24,706 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
As a pivotal inflation reading nears, investors brace for the potential shock. This article explains why wall street'...
Berkshire Hathaway disclosed a Domino's Pizza stake in late 2024, underscoring a focus on franchise-heavy, cash-gener...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
A practical, investor-focused breakdown of fermi (frmi) 2025 earnings. We unpack Q4 results, margins, and the growth ...
As Berkshire's new era unfolds, Greg Abel's first acquisition could set the tone for how the company uses its enormou...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...
With bond yields getting slashed, income-minded investors are turning to dividend stocks that blend steady payouts wi...
Dollar Tree has reshaped its business with store expansion and a strategic divestment. This guide explains why you mi...
Investors are focused on figma (FIG) 2026 earnings as the company navigates growth and profitability. This guide brea...
Markets waver as the administration frames Iran tension as a military exercise, even as missiles and drones test secu...
Global worker engagement remains stuck near crisis levels, even as AI and remote work reshape the office. This story ...